Positive Data from Phase 2 CADENCE Trial Provides Definitive Proof-of-Concept for WINREVAIRTM (sotatercept-csrk) in Adults With the Syndrome of Combined Post- and Precapillary Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction
TM
tristan manalac
via Biospace
Updated 1h ago
Source Verification
Corroboration Score: 1This story was independently reported by 1 sources. Click any source to read the original article.
Comments
0 commentsBe respectful and constructive.
Loading comments...


